Mervat Naguib

521 citations
28 papers · 313 indexed · h-index 10

Mervat Naguib

25 papers receiving 310 citations

Peers

Mervat Naguib
Comparison fields: 5 of 78
  • Hepatology 102
  • Epidemiology 154
  • Nephrology 25
  • Endocrinology, Diabetes and Metabolism 37
  • Clinical Biochemistry 12
Replace Tzu‐Hao Li with:
Tzu‐Hao Li Taiwan
Le Sun China
Sulin Zheng China
Malek Moien Ansar Iran
Liwei Shi China
Rumi Mifuji‐Moroka Japan
Mingxiang Yu China
Nary Veal France
George Tsoulfas United States
Ryujin Endo Japan
Mervat Naguib relative to Tzu‐Hao Li Taiwan Tzu‐Hao Li's profile →
Citations per field
00.5×
Tzu‐Hao Li · 1×
Citations per year

Countries citing papers authored by Mervat Naguib

Since Specialization
Citations

This map shows the geographic impact of Mervat Naguib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mervat Naguib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mervat Naguib more than expected).

Fields of papers citing papers by Mervat Naguib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mervat Naguib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mervat Naguib. The network helps show where Mervat Naguib may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mervat Naguib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mervat Naguib Line = papers co-authored together Mervat Naguib links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20231
3 20231
4 20235
5 20234
6 20222
7 202122
8 20215
9 202110
10
Single Nucleotide Polymorphisms in CDKAL1 Gene are Not Associated with Risk of Type 2 Diabetes Mellitus in a Group of Egyptian Population
20201
11 20199
12 20190
13 20191
14 201911
15 201839
16 201821
17 201812
18 201825
19 20170
20 20153

About Mervat Naguib

Mervat Naguib is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Hepatology, having authored 28 papers that have together received 313 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Diet and metabolism studies (3 papers), Autophagy in Disease and Therapy (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Diabetic Foot Ulcer Assessment and Management (2 papers), Wound Healing and Treatments (2 papers), Bariatric Surgery and Outcomes (2 papers) and Diet, Metabolism, and Disease (2 papers). The work is most often cited by research in Hepatology (102 citations), Epidemiology (154 citations) and Nephrology (25 citations). Mervat Naguib has collaborated with scholars based in Egypt, Qatar and Saudi Arabia. Frequent co-authors include Laila Ahmed Rashed, Mohamed El‐Kassas, Mohamed‐Naguib Wifi, Dalia Omran, Mohamed F. Abd‐Ellah, Ahmed F. Sherief, Mohamed Eltabbakh, Mohamed Alboraie, Ahmed A. Heikal and Dina O. Abdulazim. Their work appears in journals such as SHILAP Revista de lepidopterología, Medicine and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026